"Insuring Legionella Risks," Risk Management January/February 2019

Thomas Bernier, a partner in the firm's Toxic Tort and Environmental Practice Groups and chair of the Nanotechnology subgroup, examines what's on the horizon for insurers and policyholders with regard to Legionnaire’s disease. In "Insuring Legionella Risks," Tom and his co-author report on the history of the disease, possible common causes, the current landscape of guidelines and regulations, and what that means for companies interested in reducing risk.


Read the article: